NRX Pharmaceuticals, Inc. (NRXP)
About NRX Pharmaceuticals, Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $1.2M
- Net income
- -$28.6M
- Total assets
- $13.0M
- Market cap
- $177.2M
- Gross margin
- 58.8%
- Operating margin
- -1324.4%
- Net margin
- -2336.5%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $1.2M
- Cost of revenue
- $505.0K
- Gross profit
- $720.0K
- Operating expenses
- $16.9M
- Operating income
- -$16.2M
- Income tax
- $0
- Net income
- -$28.6M
- EPS (basic)
- $-1.34
Balance sheet
- Total assets
- $13.0M
- Current assets
- $8.9M
- Total liabilities
- $28.9M
- Current liabilities
- $28.6M
- Shareholders’ equity
- -$15.9M
Cash flow
- Operating cash flow
- -$14.1M
- Investing cash flow
- -$2.8M
- Financing cash flow
- $23.3M
- Net cash flow
- $6.4M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $177.2M
- Shares outstanding
- 47.3M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- May 25, 2021
NRX Pharmaceuticals, Inc. (NRXP) Stock Price
- Reported a net loss of $28.6M in FY2025.
- Gross margin of 58.8%, net margin -2336.5%.
- Trading 19% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review NRX Pharmaceuticals, Inc..
Write a review
News about NRX Pharmaceuticals, Inc.
News & sentiment via Polygon.io
NRX Pharmaceuticals, Inc.: frequently asked questions
Is NRX Pharmaceuticals, Inc. an American company?
NRX Pharmaceuticals, Inc. is a US-based company headquartered in Wilmington, Delaware, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is NRX Pharmaceuticals, Inc. headquartered?
NRX Pharmaceuticals, Inc. is headquartered in Wilmington, Delaware, United States.
Is NRX Pharmaceuticals, Inc. publicly traded?
Yes — NRX Pharmaceuticals, Inc. is a publicly traded company. Its stock trades under the ticker symbol NRXP on the NASDAQ.
What does NRX Pharmaceuticals, Inc. do?
NRX Pharmaceuticals, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
